Skip to content

PTSD: all studies

Page 64 of 211: studies 631 to 640 of 2,101, newest first. Back to the PTSD overview

Research

Reductions in cortisol associated with primary care brief mindfulness program for veterans with PTSD.

Medical Care December 1, 2014 Dessa Bergen-Cico, Kyle Possemato, Wilfred R Pigeon

Patients with posttraumatic stress disorder (PTSD) have significant medical morbidity, which may be mediated by hypothalamic pituitary axis (HPA) dysfunction and reflected in cortisol output. Many veterans with PTSD are hesitant to engage in trauma-focused exposure treatments; therefore briefer, non-exposure-based treatments are needed; one such promising approach is an abbreviated Primary Care...

Loving-Kindness Meditation and the Broaden-and-Build Theory of Positive Emotions Among Veterans With Posttraumatic Stress Disorder

Medical Care November 13, 2014 David J. Kearney, Carolyn Mcmanus, Carol A. Malte et al. 64 citations

BACKGROUND: Loving-kindness meditation (LKM) is a practice intended to enhance feelings of kindness and compassion for self and others. OBJECTIVES: To assess whether participation in a 12-week course of LKM for veterans with posttraumatic stress disorder (PTSD) is associated with improved positive emotions, decentering, and personal resources. RESEARCH DESIGN: In an open-pilot trial, veterans...

DOI: 10.1097/mlr.0000000000000221 (opens in new tab) Meditation Kindness Feeling Clinical psychology +8

Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.

Journal of Clinical Psychopharmacology October 2014 Colin Cameron, Diane Watson, Jeffrey D. Robinson

Nabilone is a synthetic cannabinoid that has shown promise for the treatment of posttraumatic stress disorder (PTSD)-related insomnia and nightmares as well as efficacy in the management of chronic pain. It has also been proposed for harm reduction in cannabis dependence. Its effectiveness for management of concurrent disorders in seriously mentally ill correctional populations has not been...

Design and rationale of a comparative effectiveness trial evaluating transcendental meditation against established therapies for PTSD.

Contemporary Clinical Trials September 1, 2014 Thomas Rutledge, Sanford Nidich, Robert H Schneider et al.

Although meditation therapies such as the Transcendental Meditation (TM) technique are commonly used to assist with stress and stress-related diseases, there remains a lack of rigorous clinical trial research establishing the relative efficacy of these treatments overall and for populations with psychiatric illness. This study uses a comparative effectiveness design to assess the relative...

DOI: 10.1016/j.cct.2014.07.005 (opens in new tab) Full text (opens in new tab) Cognitive behavioral therapy Posttraumatic stress disorder Prolonged exposure Transcendental meditation

Trauma-related altered states of consciousness in women with BPD with or without co-occurring PTSD

European Journal of Psychotraumatology August 18, 2014 Paul Frewen, Nikolaus Kleindienst, Ruth A. Lanius et al.

Background A “4-D model” was recently described as a theoretical framework for categorizing trauma-related symptoms into four phenomenological dimensions (the experience of time, thought, body, and emotion) that can present either in the form of normal waking consciousness (NWC) or as dissociative experiences, that is, trauma-related altered states of consciousness (TRASC). Methods The present...

Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.

Clinical drug investigation August 2014 Pablo Roitman, Raphael Mechoulam, Rena Cooper-Kazaz et al.

Many patients with post-traumatic stress disorder (PTSD) achieve but partial remission with current treatments. Patients with unremitted PTSD show high rates of substance abuse. Marijuana is often used as compassion add-on therapy for treatment-resistant PTSD. This open-label study evaluates the tolerance and safety of orally absorbable Δ(9)-tetrahydrocannabinol (THC) for chronic PTSD. Ten...

Breathing‐Based Meditation Decreases Posttraumatic Stress Disorder Symptoms in U.S. Military Veterans: A Randomized Controlled Longitudinal Study

Journal of Traumatic Stress August 1, 2014 Emma M Seppala, Jack B. Nitschke, Dana Tudorascu et al. 180 citations

Given the limited success of conventional treatments for veterans with posttraumatic stress disorder (PTSD), investigations of alternative approaches are warranted. We examined the effects of a breathing-based meditation intervention, Sudarshan Kriya yoga, on PTSD outcome variables in U.S. male veterans of the Iraq or Afghanistan war. We randomly assigned 21 veterans to an active (n = 11) or...

DOI: 10.1002/jts.21936 (opens in new tab) Meditation Anxiety disorder Intervention counseling Randomized controlled trial +5

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder.

Annals of Pharmacotherapy July 2014 C Michael White

Review the current literature assessing the role of 3,4-methylenedioxymethamphetamine (MDMA) on posttraumatic stress disorder (PTSD). OVID MEDLINE search (1960-February 2014) using the terms MDMA, 3,4-methylenedioxymethamphetamine, Molly, and Ecstasy crossed with posttraumatic stress disorder with backwards citation tracking using references from procured articles. English language studies...

Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder

JAMA Psychiatry April 16, 2014 Adriana Feder, Michael K. Parides, James W. Murrough et al. 618 citations

IMPORTANCE: Few pharmacotherapies have demonstrated sufficient efficacy in the treatment of posttraumatic stress disorder (PTSD), a chronic and disabling condition. OBJECTIVE: To test the efficacy and safety of a single intravenous subanesthetic dose of ketamine for the treatment of PTSD and associated depressive symptoms in patients with chronic PTSD. DESIGN, SETTING, AND PARTICIPANTS:...

Significant reductions in posttraumatic stress symptoms in Congolese refugees within 10 days of Transcendental Meditation practice.

Journal of Traumatic Stress February 1, 2014 Brian Rees, Fred Travis, David Shapiro et al.

This follow-up pilot study tested whether Transcendental Meditation® (TM) practice would significantly reduce symptoms of posttraumatic stress in Congolese refugees within 10 days after instruction. The Posttraumatic Stress Disorder Checklist-Civilian (PCL-C) was administered to nonmatched waitlist controls from a previous study 3 times over a 90-day period. Within 8 days of the third baseline...